<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: We assessed the association between risk factors and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) in an observational study of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients from the Swedish National <z:mp ids='MP_0002055'>Diabetes</z:mp> Register </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A derivation sample of 24,288 patients, aged 30-74 years, 15.3% with previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, baseline 2002, 2488 CVD events when followed for 5 years until 2007 </plain></SENT>
<SENT sid="2" pm="."><plain>A separate validation data set of 4906 patients, baseline 2003, 522 CVD events when followed for 4 years </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Adjusted hazard ratios at Cox regression for fatal/nonfatal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> were: <z:hpo ids='HP_0003674'>onset</z:hpo>-age 1.59, <z:mp ids='MP_0002055'>diabetes</z:mp> duration 1.55, total-cholesterol-to-<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> ratio 1.20, HbA1c 1.12, systolic BP 1.09, BMI 1.07 (1 SD increase in natural log continuous variables); males 1.41, smoker 1.35, <z:mp ids='MP_0002959'>microalbuminuria</z:mp> 1.27, macroalbuminuria 1.53, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> 1.50, previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> 1.98 (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.001 except BMI p=0.0018) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 12 variables were used to elaborate an equation for 5-year <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk in the derivation dataset: mean 5-year risk 11.9Â±8.4% </plain></SENT>
<SENT sid="5" pm="."><plain>Calibration in the validation dataset was adequate: ratio predicted 4-year risk/observed rate 0.97 </plain></SENT>
<SENT sid="6" pm="."><plain>Discrimination was sufficient: C statistic 0.72, sensitivity 51% and specificity 78% for top quartile </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: This <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk model from a large observational study of patients in routine care showed adequate calibration and discrimination, and can be useful for clinical practice </plain></SENT>
</text></document>